AN2 Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating income | −$21.6M | −$42.3M | −$69.6M | −$56.8M | −$38.1M |
| Net income | −$21.5M | −$41.0M | −$64.7M | −$51.3M | −$35.2M |
| Operating cash flow | −$20.5M | −$33.5M | −$53.3M | −$49.3M | −$29.8M |
| Cash | $12.1M | $27.2M | $15.6M | $21.4M | $19.9M |
| Shares outstanding | 2.7M | 19.4M | 29.7M | 29.9M | 27.4M |